The new ISBT office - International Society for Blood Transfusion
The new ISBT office - International Society for Blood Transfusion
The new ISBT office - International Society for Blood Transfusion
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Contents<br />
14<br />
Judith Chapman<br />
05 22<br />
Editorial<br />
1 test, 3 results, real-time virus discrimination<br />
Now available!<br />
cobas ® TaqScreen MPX Test, v2.0 (CE-IVD)*<br />
Our <strong>new</strong>est NAT 1 test <strong>for</strong> blood screening offers:<br />
• Real-time detection and identification of 3 viruses<br />
in a single test (HIV, HCV and HBV)<br />
• 5 critical viral targets (HIV-1 Group M, HIV-1 Group O,<br />
HIV-2, HCV and HBV) in one easy-to-use assay<br />
• Increased operational efficiency by removing<br />
the need <strong>for</strong> viral discriminatory testing<br />
• Improved sensitivity compared to the previous version<br />
of the test<br />
• Increased inclusivity of viral targets based on <strong>new</strong><br />
viral sequences<br />
• Improved workflow on a single plat<strong>for</strong>m<br />
<strong>The</strong> most comprehensive NAT assay menu on<br />
a single plat<strong>for</strong>m<br />
<strong>The</strong> fully automated cobas s 201 system is an easy to-use,<br />
reliable blood screening plat<strong>for</strong>m used by over 250 blood<br />
banks worldwide.<br />
Maximize efficiency with ready-to-use reagent kits that<br />
cover seven major viruses: HIV-1, HIV-2, HCV, HBV, WNV,<br />
HAV** and B19V.**<br />
1<br />
Nucleic acid amplification technology<br />
4<br />
13<br />
24<br />
In focus<br />
W.G. van Aken’s reflections on <strong>ISBT</strong>; Robert Beal’s reflections on <strong>ISBT</strong>;<br />
Hans Erik Heier’s reflections on <strong>ISBT</strong>; Francine Décary’s reflections on <strong>ISBT</strong>;<br />
From <strong>ISBT</strong> Central Office<br />
From the President; From the Secretary-General; <strong>The</strong> <strong>new</strong> <strong>ISBT</strong> Office;<br />
Opening speech from the President; Membership Re<strong>new</strong>als; Welcome<br />
to our <strong>new</strong> members; Statutes and by laws; New members <strong>ISBT</strong>; 32nd<br />
<strong>International</strong> Congress of the <strong>ISBT</strong>, Cancún<br />
Regional <strong>new</strong>s<br />
Automated platelet pooling implemented in Russia; First <strong>International</strong><br />
Conference of Saudi <strong>Society</strong> of <strong>Transfusion</strong> Medicine; “Perspectives in<br />
Cell- and Gene-Based Medicines” – <strong>The</strong> Role of <strong>Transfusion</strong> Medicine<br />
and Hemotherapy, Meeting Report; Afghanistan’s Minister of Public<br />
Health, Suraya Dalil, MD, MPH encourages Afghans to donate blood;<br />
Development of <strong>Transfusion</strong> Medicine in Potosí - Bolivia; New Board of<br />
the Bolivian <strong>Society</strong> of Immunohematology and <strong>Transfusion</strong> Medicine;<br />
<strong>The</strong> Slovenian National Congress of <strong>Transfusion</strong> Medicine<br />
and Haematology<br />
President Silvano Wendel Secretary General Geoff Daniels Executive Director Judith Chapman<br />
Design Tomorrow Design Photography <strong>Transfusion</strong> Today Advertising Monique van Dorp,<br />
communication@isbtweb.org<br />
Statements and opinions expressed in <strong>Transfusion</strong> Today are those of the individual contributors and<br />
not that of <strong>ISBT</strong>. Reproduction in whole or part requires permission by the publisher. <strong>ISBT</strong> members<br />
need not obtain permission if proper credit is given.<br />
This issue of <strong>Transfusion</strong> Today features<br />
articles by four previous Presidents of<br />
<strong>ISBT</strong>. <strong>The</strong> idea came from Silvano Wendel<br />
our current President following the opening<br />
of the <strong>new</strong> <strong>ISBT</strong> <strong>office</strong> in Amsterdam.<br />
Those of us working at the <strong>office</strong> agree<br />
that we very much enjoy working in our<br />
<strong>new</strong> premises. You can read more about<br />
the <strong>office</strong> in From the Central Office.<br />
I recently spent half a day with Francine<br />
Décary when we reminisced about our<br />
time together on the <strong>ISBT</strong> Board; Francine<br />
was the past President and I was the<br />
Regional Director <strong>for</strong> Western Europe.<br />
During my period on the Board we<br />
prepared the strategy <strong>for</strong> the period 2009<br />
– 2012. <strong>The</strong> strategy <strong>for</strong> 2012 - 2015<br />
was developed at a Board retreat in June<br />
2011 and we shared the major points<br />
with you in the last edition of <strong>Transfusion</strong><br />
Today. One of the goals is to establish<br />
how <strong>ISBT</strong> can retain its current members,<br />
determine how we can give added value<br />
to our members and identify a strategy <strong>for</strong><br />
increasing recruitment. A piece of research<br />
work has recently been completed on the<br />
membership and we hope to share more<br />
in<strong>for</strong>mation with you on the findings and<br />
how we will initiate the recommendations<br />
over the course of the year.<br />
In the regional pages you will find reports of<br />
two meetings that the <strong>ISBT</strong> Academy has<br />
supported in the last three months. Don’t<br />
<strong>for</strong>get that you can apply <strong>for</strong> <strong>ISBT</strong> Academy<br />
support <strong>for</strong> local educational events.<br />
ROCHE, COBAS, COBAS S, LIFE NEEDS ANSWERS and<br />
TAQSCREEN are trademarks of Roche.<br />
©2012 Roche Molecular Systems, Inc. All rights reserved.<br />
http://molecular.roche.com<br />
*Not available in the US<br />
**CE-IVD. <strong>The</strong> duplex test <strong>for</strong> HAV and B19V has been filed with the<br />
FDA under a Master File. It is available to US laboratories that meet<br />
specific FDA requirements.<br />
Send all correspondence to <strong>ISBT</strong> - Marnixstraat 317, 1016 TB, Amsterdam, <strong>The</strong> Netherlands.<br />
T +31 20 7601 760, F +31 20 7601 761, communication@isbtweb.org.<br />
Platinum member<br />
Gold members<br />
Preparations are almost complete <strong>for</strong> the<br />
32nd <strong>International</strong> Congress in Cancún.<br />
Please come and visit the <strong>ISBT</strong> lounge<br />
and the <strong>ISBT</strong> stand. I hope to see many of<br />
you there.<br />
<strong>Transfusion</strong> Today | Number 91, June 2012<br />
3